Advertisement

Reactions Weekly

, Volume 1781, Issue 1, pp 23–23 | Cite as

Afatinib/amrubicin

Liver dysfunction and lack of efficacy: case report
Case report
  • 10 Downloads

Reference

  1. Murano C, et al. Osimertinib as treatment for egfr exon 20 insertion-positive lung adenocarcinoma. EXCLI Journal 18: 893-898, Jan 2019. Available from: URL: http://doi.org/10.17179/excli2019-1786 - Japan

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations